Susquehanna International Group’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-27,834
| Closed | -$546K | – | 10772 |
|
|
2017
Q4 | $463K | Buy |
+27,834
| New | +$510K | ﹤0.01% | 6789 |
|
|
2017
Q2 | – | Sell |
-79,985
| Closed | -$1.18M | – | 10267 |
|
|
2017
Q1 | $1.01M | Sell |
79,985
-67,763
| -46% | -$818K | ﹤0.01% | 5107 |
|
|
2016
Q4 | $1.96M | Buy |
+147,748
| New | +$2.53M | ﹤0.01% | 4105 |
|
|
2016
Q3 | – | Sell |
-33,367
| Closed | -$897K | – | 9437 |
|
|
2016
Q2 | $962K | Sell |
33,367
-40,763
| -55% | -$1.33M | ﹤0.01% | 4957 |
|
|
2016
Q1 | $2.37M | Buy |
74,130
+6,279
| +9% | +$221K | ﹤0.01% | 3439 |
|
|
2015
Q4 | $2.9M | Sell |
67,851
-262
| -0.4% | -$10.5K | ﹤0.01% | 3342 |
|
|
2015
Q3 | $2.4M | Buy |
68,113
+18,406
| +37% | +$829K | ﹤0.01% | 3915 |
|
|
2015
Q2 | $2.28M | Sell |
49,707
-57,874
| -54% | -$2.75M | ﹤0.01% | 4430 |
|
|
2015
Q1 | $5.04M | Buy |
107,581
+80,511
| +297% | +$3.2M | ﹤0.01% | 2734 |
|
|
2014
Q4 | $858K | Sell |
27,070
-10,223
| -27% | -$299K | ﹤0.01% | 6162 |
|
|
2014
Q3 | $884K | Sell |
37,293
-63,221
| -63% | -$1.62M | ﹤0.01% | 6170 |
|
|
2014
Q2 | $3.02M | Buy |
100,514
+22,399
| +29% | +$604K | ﹤0.01% | 3914 |
|
|
2014
Q1 | $2.06M | Buy |
78,115
+58,945
| +307% | +$1.47M | ﹤0.01% | 4301 |
|
|
2013
Q4 | $482K | Buy |
+19,170
| New | +$428K | ﹤0.01% | 6764 |
|
|
2013
Q3 | – | Sell |
-39,615
| Closed | -$818K | – | 8987 |
|
|
2013
Q2 | $790K | Buy |
+39,615
| New | +$703K | ﹤0.01% | 5372 |
|
Susquehanna International Group's IPXL Position: Q1 2018 in Review
Susquehanna International Group sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 27,834 shares — an estimated $546K sold.
Susquehanna International Group first reported a position in IPXL in Q2 2013 and held it in 15 quarters. The position peaked at $5.04M in Q1 2015. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.
- Susquehanna International Group reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
- Susquehanna International Group sold 27,834 Impax Laboratories, Inc. shares in Q1 2018, an estimated $546K.
- Susquehanna International Group first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 15 quarters.
- Susquehanna International Group's Impax Laboratories, Inc. position peaked at $5.04M in Q1 2015.
- 188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.
Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.